Published in Support Care Cancer on January 24, 2015
Characteristics of patients with an unplanned admission to an acute palliative care unit. Intern Emerg Med (2017) 0.77
West Nile Virus Encephalitis in a Patient with Neuroendocrine Carcinoma. Case Rep Oncol Med (2016) 0.75
Understanding cognition in older patients with cancer. J Geriatr Oncol (2016) 0.75
The Frequency, Characteristics, and Outcomes Among Cancer Patients With Delirium Admitted to an Acute Palliative Care Unit. Oncologist (2015) 0.75
Clinical Assessment and Management of Delirium in the Palliative Care Setting. Drugs (2017) 0.75
Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med (1990) 16.54
Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med (2000) 4.60
The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med (2001) 4.12
The Memorial Delirium Assessment Scale. J Pain Symptom Manage (1997) 3.55
Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci (2001) 3.35
Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage (1995) 2.51
Delirium in advanced cancer patients. Palliat Med (2004) 1.92
Delirium: an independent predictor of functional decline after cardiac surgery. J Am Geriatr Soc (2010) 1.82
The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics (2002) 1.76
Persistent delirium predicts greater mortality. J Am Geriatr Soc (2009) 1.66
Diagnosis and management of delirium near the end of life. Ann Intern Med (2001) 1.57
Detection of delirium in the acute hospital. Age Ageing (2009) 1.42
Delirium superimposed on dementia in a community-dwelling managed care population: a 3-year retrospective study of occurrence, costs, and utilization. J Gerontol A Biol Sci Med Sci (2005) 1.39
Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer (2009) 1.20
Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Manage (1995) 1.18
The misdiagnosis of delirium. Psychosomatics (1997) 1.13
Misdiagnosing delirium as depression in medically ill elderly patients. Arch Intern Med (1996) 1.12
Prevalence, detection and treatment of delirium in terminal cancer inpatients: a prospective survey. Jpn J Clin Oncol (2008) 0.98
The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response. Palliat Support Care (2004) 0.96
Misdiagnosed delirium in patient referrals to a university-based hospital psychiatry department. Psychosomatics (2008) 0.93
Delirium in patients with advanced cancer. Hematol Oncol Clin North Am (2002) 0.92
Delirium detection in clinical practice and research: critique of current tools and suggestions for future development. J Psychosom Res (2008) 0.88
Palliating delirium in patients with cancer. Lancet Oncol (2009) 0.87
Delirium in advanced cancer leading to distress in patients and family caregivers. J Palliat Care (2009) 0.87
Delirium: patient characteristics that predict a missed diagnosis at psychiatric consultation. Gen Hosp Psychiatry (2007) 0.86
Psychiatric issues in palliative care: recognition of delirium in patients enrolled in hospice care. Palliat Support Care (2008) 0.86
Reversibility of delirium in terminally ill patients and predictors of mortality. Palliat Med (2008) 0.83
An update on the use of antipsychotics in the treatment of delirium. Palliat Support Care (2008) 0.80
Delirium with severe symptom expression related to hypercalcemia in a patient with advanced cancer: an interdisciplinary approach to treatment. J Pain Symptom Manage (2008) 0.80
Clinical practice guidelines for delirium management: potential application in palliative care. J Pain Symptom Manage (2014) 0.79
Opioids masquerading as delirium in a patient with cancer pain and obstructive sleep apnea. J Palliat Med (2008) 0.78
Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development. J Pain Symptom Manage (2014) 0.78
Pain and terminal delirium research in the elderly. Clin Geriatr Med (2005) 0.77
Characteristics, interventions, and outcomes of misdiagnosed delirium in cancer patients. Palliat Support Care (2010) 0.77
Delirium in the elderly: relationship of clinical symptoms to outcome. Dementia (1993) 0.77
Differences in characteristics and outcome of delirium as based on referral patterns. Psychosomatics (2006) 0.77
The assessment and management of hypoactive delirium. Med Health R I (2007) 0.75
Definition and classification of cancer cachexia: an international consensus. Lancet Oncol (2011) 7.78
Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol (2013) 5.07
Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain (2006) 4.96
Availability and integration of palliative care at US cancer centers. JAMA (2010) 4.51
Palliative cancer care a decade later: accomplishments, the need, next steps -- from the American Society of Clinical Oncology. J Clin Oncol (2009) 3.36
Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center. Cancer (2009) 2.58
Behavioral tests after intracerebral hemorrhage in the rat. Stroke (2002) 2.46
Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer (2011) 2.15
Dehydration in cancer patients: to treat or not to treat. J Support Oncol (2004) 2.15
The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med (2013) 2.00
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila) (2009) 1.99
Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer (2010) 1.97
Delirium in advanced cancer patients. Palliat Med (2004) 1.92
Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg (2006) 1.82
Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliat Med (2008) 1.76
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain (2006) 1.72
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine (2004) 1.70
Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med (2005) 1.67
Patient-physician communication about code status preferences: a randomized controlled trial. Cancer (2013) 1.66
NCCN clinical practice guidelines in oncology: palliative care. J Natl Compr Canc Netw (2009) 1.66
Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist (2011) 1.61
Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial. J Clin Oncol (2013) 1.59
An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer (2010) 1.59
The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med (2010) 1.57
Palliative management of fatigue at the close of life: "it feels like my body is just worn out". JAMA (2007) 1.57
Bedside clinical signs associated with impending death in patients with advanced cancer: preliminary findings of a prospective, longitudinal cohort study. Cancer (2015) 1.56
Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol (2004) 1.55
Inpatient rehabilitation improved functional status in asthenic patients with solid and hematologic malignancies. Am J Phys Med Rehabil (2011) 1.54
Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol (2002) 1.50
Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer (2014) 1.49
Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center. J Palliat Med (2010) 1.48
Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer (2006) 1.45
Cancer patients' perceptions regarding the value of the physical examination: a survey study. Cancer (2014) 1.44
The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report. J Palliat Med (2014) 1.39
Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage (2010) 1.37
Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer (2006) 1.36
Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery (2006) 1.35
Access to palliative care among patients treated at a comprehensive cancer center. Oncologist (2012) 1.34
Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med (2007) 1.32
CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma. Cancer Res (2012) 1.32
Quantity, design, and scope of the palliative oncology literature. Oncologist (2011) 1.32
The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage (2011) 1.30
Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer. Clin Cancer Res (2002) 1.26
Pain and emotional distress in leukemia patients at diagnosis. Leuk Res (2009) 1.26
Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer. Clin Cancer Res (2002) 1.26
Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer (2004) 1.25
The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report. Oncologist (2011) 1.24
A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician (2012) 1.24
Spirituality, religiosity, and spiritual pain in advanced cancer patients. J Pain Symptom Manage (2011) 1.23
Targeted agent use in cancer patients at the end of life. J Pain Symptom Manage (2012) 1.22
Symptom control in palliative care--Part II: cachexia/anorexia and fatigue. J Palliat Med (2006) 1.22
Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother (2004) 1.22
Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res (2002) 1.21
A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis. Clin Cancer Res (2010) 1.21
Assessing hope at the end of life: validation of an experience of hope scale in advanced cancer patients. Palliat Support Care (2004) 1.20
Consensus guideline on parenteral methadone use in pain and palliative care. Palliat Support Care (2008) 1.20
Can this patient be discharged home? Factors associated with at-home death among patients with cancer. J Clin Oncol (2011) 1.20
Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol (2008) 1.19
Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model. Cancer (2010) 1.19
Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med (2009) 1.18
A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients. Eur J Cancer (2011) 1.17
Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med (2008) 1.17
Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use. J Palliat Med (2008) 1.15
Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center. J Palliat Med (2007) 1.14
Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer (2014) 1.14
NOPPAIN: a nursing assistant-administered pain assessment instrument for use in dementia. Dement Geriatr Cogn Disord (2004) 1.14
Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team. Cancer (2009) 1.13
Symptom control in palliative care--Part III: dyspnea and delirium. J Palliat Med (2006) 1.13
Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer (2004) 1.12
Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer. Cancer (2011) 1.12
Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med (2008) 1.12
Opioid switching: a systematic and critical review. Cancer Treat Rev (2006) 1.10
Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates. J Palliat Med (2013) 1.10
The impact of palliative care consultation on symptom assessment, communication needs, and palliative interventions in pediatric patients with cancer. J Palliat Med (2009) 1.09
The assessment and management of delirium in cancer patients. Oncologist (2009) 1.08
Botulinum toxin injection and phenol nerve block for reduction of end-of-life pain. J Palliat Med (2013) 1.08
Dual opioid therapy using methadone as a coanalgesic. Expert Opin Drug Saf (2014) 1.08
Symptom control in palliative care--Part I: oncology as a paradigmatic example. J Palliat Med (2006) 1.08
Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients. Cancer (2011) 1.07
The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med (2006) 1.06
Thrombin-receptor activation and thrombin-induced brain tolerance. J Cereb Blood Flow Metab (2002) 1.06
Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer (2008) 1.06
Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations. Breast Cancer Res Treat (2011) 1.06
Concepts and definitions for "supportive care," "best supportive care," "palliative care," and "hospice care" in the published literature, dictionaries, and textbooks. Support Care Cancer (2012) 1.06
Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-alpha-308 G/A IL6-174G/C and IL8-251T/A. Cancer Epidemiol Biomarkers Prev (2007) 1.05
Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival. J Clin Oncol (2002) 1.05
A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras. Mol Cancer Ther (2008) 1.04
Parents dying of cancer and their children. Palliat Support Care (2004) 1.04
Racial disparities in the use of hospice services according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer. Cancer (2010) 1.03
Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. J Pain Symptom Manage (2009) 1.02
Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study. J Pain Symptom Manage (2004) 1.02
Clinical response to an outpatient palliative care consultation in patients with advanced cancer and cancer pain. J Pain Symptom Manage (2012) 1.02
The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study. J Palliat Med (2012) 1.02
Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther (2010) 1.02
Plasminogen activator inhibitor-1 induction after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab (2002) 1.00
The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer (2006) 1.00
Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials. Cancer (2012) 0.99
Routine symptom assessment: good for practice and good for business. Support Care Cancer (2008) 0.97